Hans Biomed Corp
042520
Company Profile
Business description
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.
Contact
No.7, Jeong-i-ro 8-gil
Songpa-gu
Seoul
KORT: +82 24662266
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2025
Employees
263
Stocks News & Analysis
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
stocks
After earnings, is Nvidia stock a buy, a sell, or fairly valued?
No signs of a slowdown in demand for Nvidia’s chips, and the long-term picture looks bright.
stocks
Short-term pain for long-term gain for undervalued ASX share
Cost reductions lower our profit estimates but should lead to improved long-term outcomes.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,075.90 | 35.70 | 0.39% |
| CAC 40 | 7,719.71 | 65.46 | 0.86% |
| DAX 40 | 23,594.80 | 107.47 | 0.46% |
| Dow JONES (US) | 45,271.23 | 24.58 | -0.05% |
| FTSE 100 | 9,177.99 | 61.30 | 0.67% |
| HKSE | 25,037.73 | 305.70 | -1.21% |
| NASDAQ | 21,497.73 | 218.10 | 1.02% |
| Nikkei 225 | 42,519.70 | 580.81 | 1.38% |
| NZX 50 Index | 13,125.38 | 50.57 | 0.39% |
| S&P 500 | 6,448.26 | 32.72 | 0.51% |
| S&P/ASX 200 | 8,810.30 | 43.00 | 0.49% |
| SSE Composite Index | 3,738.32 | 75.23 | -1.97% |